Esophageal Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Esophageal Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-11-24Clinical Trial Update: A Study of CS1001 in Subjects With Esophageal Squamous Cell Carcinoma [Phase 3]
Phase 3 trial update for CS1001 in unresectable locally advanced, recurrent or metastatic esophageal squamous cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: Preoperative Anti-PD-1 Antibody Combined With Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of Esophagus [Phase 1]
Phase 1 trial evaluating preoperative anti-PD-1 antibody combined with chemoradiotherapy for locally advanced esophageal squamous cell carci…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Concurrent Chemoradiotherapy for Stage IVB Esophageal Squamous Cell Carcinoma（EC-CRT-003） [Phase 2]
A Phase 2 clinical trial update for concurrent chemoradiotherapy in metastatic esophageal squamous cell carcinoma is underway, with status c…
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma [Phase 3]
Phase 3 trial evaluating tislelizumab in combination with chemotherapy as first-line treatment for advanced esophageal squamous cell carcino…
-
CLINICAL_TRIALS trial_result · 2023-10-24Clinical Trial Update: Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma ( ORIENT-15 ) [Phase 3]
Phase 3 trial evaluating sintilimab plus chemotherapy versus placebo with chemotherapy in esophageal squamous cell carcinoma completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: IBI110 Combined With Sintilimab in Second-line Advanced or Metastatic Esophageal Squamous Cell Carcinoma(ESCC) [Phase 2]
Phase 2 trial update investigating IBI110 with sintilimab for second-line advanced or metastatic esophageal squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: Neoadjuvant Pembrolizumab Plus Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial update on neoadjuvant pembrolizumab plus chemotherapy for resectable locally advanced esophageal squamous cell carcinoma has c…
-
CLINICAL_TRIALS trial_result · 2023-09-26Clinical Trial Update: DV Combined With PD-1 and Platinum-based First-line Treatment in Patients With HER2 IHC2+/3+ ESCC [Phase 1, Phase 2]
Clinical trial update for DV in combination with PD-1 and platinum-based first-line therapy in HER2 IHC 2+/3+ esophageal squamous cell carci…
-
CLINICAL_TRIALS trial_result · 2023-09-11Clinical Trial Update: Cadonilimab/Anlotinib in Locally Advanced or Relapsed/Metastatic ESCC Patients After Failure of PD-1 Combined With Platinum-containing Chemotherapy [Phase 2]
Phase 2 clinical trial evaluating Cadonilimab plus Anlotinib in locally advanced or relapsed/metastatic esophageal squamous cell carcinoma a…
-
CLINICAL_TRIALS trial_result · 2023-08-08Clinical Trial Update: Neoadjuvant Treatment of Cadonilimab Combined Albumin-paclitaxel, Cisplatin and Fluorouracil for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 neoadjuvant trial evaluating cadonilimab plus albumin-paclitaxel, cisplatin, and fluorouracil for resectable locally advanced esopha…
-
CLINICAL_TRIALS trial_result · 2023-08-07Clinical Trial Update: Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab [Phase 1, Phase 2]
A Phase 1/2 trial evaluating letetresgene autoleucel (lete-cel) T-cells targeting NY-ESO-1/LAGE-1a, alone or with pembrolizumab, in advanced…
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: Comparing 61.2 Gy Radiotherapy Dose Versus 50.4 Gy Radiotherapy Dose for Locally Advanced Esophageal Carcinoma [Phase 3]
Phase 3 clinical trial comparing 61.2 Gy versus 50.4 Gy radiotherapy dose for locally advanced esophageal carcinoma (esophageal squamous cel…
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17) [Phase 2]
Phase II study evaluating postoperative concurrent chemoradiotherapy for esophageal squamous cell carcinoma (ESO-Shanghai 17) is active but …
-
CLINICAL_TRIALS trial_result · 2023-06-29Clinical Trial Update: Tislelizumab With Chemotherapy or Radiation for Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma (TINES) [Phase 4]
Phase 4 trial evaluating tislelizumab with chemotherapy or radiation as neoadjuvant therapy for esophageal squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-05-18Clinical Trial Update: Anlotinib Combined With TQB2450 (PD-L1 Inhibitor) in the Treatment of Advanced Esophageal Squamous Cell Carcinoma(ESCC) [Phase 2]
Phase 2 trial evaluating the combination of anlotinib with PD-L1 inhibitor TQB2450 in advanced esophageal squamous cell carcinoma is ongoing…
-
CLINICAL_TRIALS trial_result · 2023-04-19Clinical Trial Update: To Evaluate the Efficacy and Safety of Afatinib for Advanced ALTRK-negative ESCC [Phase 2]
Phase 2 trial update evaluating afatinib for efficacy and safety in advanced ALTRK-negative esophageal squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: A Clinical Trial Comparing HLX10 With Placebo Combined With Chemotherapy (Cisplatin + 5-fu) in the First-line Treatment of Locally Advanced/Metastatic Esophageal Squamous Cell Carcinoma (ESCC) [Phase 3]
Phase 3 trial comparing HLX10 with placebo plus chemotherapy in first-line locally advanced or metastatic esophageal squamous cell carcinoma…
-
CLINICAL_TRIALS trial_result · 2023-04-10Clinical Trial Update: Pembrolizumab Plus Paclitaxel, Cisplatin Followed by Surgery for Locally Advanced ESCC (KEYSTONE-001) [Phase 2]
Phase 2 trial exploring pembrolizumab with paclitaxel and cisplatin followed by surgery for locally advanced esophageal squamous cell carcin…
-
CLINICAL_TRIALS trial_result · 2023-03-21Clinical Trial Update: Z650 in Advanced Esophageal Squamous Cell Carcinoma With EGFR Over Expression or Gene Amplification [Phase 1, Phase 2]
Clinical trial update for Z650 in advanced esophageal squamous cell carcinoma with EGFR overexpression or gene amplification completed phase…
-
CLINICAL_TRIALS trial_result · 2023-03-14Clinical Trial Update: Tislelizumab Combined With Neoadjuvant Radiotherapy and Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma. [Phase 2]
Phase 2 clinical trial exploring tislelizumab with neoadjuvant radiotherapy and chemotherapy for resectable esophageal squamous cell carcino…
-
CLINICAL_TRIALS trial_result · 2023-03-06Clinical Trial Update: Tucidinostat Plus PD-1 Inhibitor and Bevacizumab for Advanced Esophagus Cancer, AEG, Gastric Cancer [Phase 2]
Phase 2 trial investigating tucidinostat with a PD-1 inhibitor and bevacizumab in advanced esophageal and gastric cancers; status is current…
-
CLINICAL_TRIALS trial_result · 2023-02-17Clinical Trial Update: Efficacy and Safety of TPF Induction Chemotherapy for Borderline-resectable Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial update on induction chemotherapy (TPF) for borderline-resectable esophageal squamous cell carcinoma, reporting efficacy and sa…
-
CLINICAL_TRIALS trial_result · 2023-02-17Clinical Trial Update: Study of Icotinib Hydrochloride in Treating Patients With Recurrent or Metastatic Esophageal Cancer After Failure of Conventional Chemotherapy [Phase 2]
Phase 2 trial evaluating icotinib hydrochloride in recurrent or metastatic esophageal squamous cell carcinoma after failure of conventional …
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: Apatinib for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment [Phase 2]
Phase 2 trial updating apatinib for esophageal squamous cell carcinoma after standard-treatment failure has completed.
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: Endostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal Cancer [Phase 2]
Phase 2 clinical trial evaluating Endostar in combination with Paclitaxel and Nedaplatin for recurrent or metastatic esophageal cancer has c…